|
|
|
|
|
|
|
Soleno Therapeutics- Inc. (SLNO)
|
|
2.25 -0.01 (-0.44%)
|
06-19 11:18
|
|
Open:
|
2.26
|
Pre. Close:
|
2.26
|
|
High:
|
2.26
|
Low:
|
2.2
|
|
Volume:
|
1,903
|
Market Cap:
|
44M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.404 - 2.416
|
2.416 - 2.426
|
|
Low:
|
2.174 - 2.186
|
2.186 - 2.196
|
|
Close:
|
2.242 - 2.261
|
2.261 - 2.277
|
|
|
|
Technical analysis (as of: 2018-06-19 11:32:43 AM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 2.80 One year: 3.27
|
|
Support:
|
Support1: 2.00  Support2: 1.75
|
|
Resistance:
|
Resistance1:
2.40 Resistance2: 2.80
|
|
Pivot:
|
2.11
|
|
Moving Averages:
|
MA(5): 2.22 MA(20): 2.10
MA(100): 1.83 MA(250): 2.08 
|
|
MACD:
|
MACD(12,26):
0.10 Signal(12,26,9): 0.08
|
|
%K %D:
|
%K(14,3): 73.00 %D(3): 71.27
|
|
RSI:
|
RSI(14): 65.12
|
|
52-Week:
|
High: 3.75
Low: 1.317 Change(%): -21.7
|
|
Average Vol(K):
|
3-Month: 3132
10-Days 5008
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.SLNO has closed below upper band by 12.2%. Bollinger Bands are 12.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-16T10:15:25-04:00
Soleno Therapeutics reports Q1 results
2018-04-27T12:20:00-04:00
INSYS launches mid-stage study of CBD in rare obesity disorder
2018-02-21T11:49:59-05:00
Your Daily Pharma Scoop: Portola Update, Wave Life Sciences To Collaborate With Takeda, AbbVie Reports Data For Egolix
2017-12-21T00:18:09-05:00
Daily Insider Ratings Round Up 12/19/17: BAS, GBT, PSEC, DRNA, SLNO
2017-12-12T12:50:18-05:00
Soleno Therapeutics secures private $15M capital raise; shares up 2%
2017-12-11T07:00:00-05:00
Your Daily Pharma Scoop: Celgene Upside, Erytech Tumbles, Novartis Neulasta Biosimilar
2017-12-08T08:42:47-05:00
Soleno up 16% premarket on move away from Capnia
2017-10-12T09:55:41-04:00
EMA advisory group backs Orphan Drug tag for Soleno's DCCR for Prader-Willi syndrome; shares up 2%
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
